Drug
Lixivaptan clinical trials
- studies test it
- 10
- open now
- 0
- in phase 3
- 7
- first study started
- 2007
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
10 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
- Phase 3
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Studies
Open first, then newest update. How each study uses lixivaptan is read from its arms, and is right about nine times in ten.
Testing it · 10
- Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303TerminatedPhase 3Palladio BiosciencesNCT05208866Written as Lixivaptan
- Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney DiseaseTerminatedPhase 3Palladio BiosciencesNCT04152837Written as Lixivaptan
- Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney DiseaseTerminatedPhase 3Palladio BiosciencesNCT04064346Written as Lixivaptan
- The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney DiseaseCompletedPhase 2Palladio BiosciencesNCT03487913Written as Lixivaptan
- Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart FailureCompletedPhase 2CardioKine Inc.NCT01055912Written as Lixivaptan
- THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient EvaluationCompletedPhase 3CardioKine Inc.NCT00578695Written as lixivaptan
- Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic HyponatremiaCompletedPhase 3CardioKine Inc.NCT00660959Written as lixivaptan
- A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic HyponatremiaCompletedPhase 3CardioKine Inc.NCT00876798Written as Lixivaptan
- A Study to Define the ECG Effects of Lixivaptan Compared to Placebo and Moxifloxacin in Healthy Adult Men and Women: A Thorough ECG StudyCompletedPhase 1CardioKine Inc.NCT00675701Written as lixivaptan
- International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic HyponatremiaWithdrawnPhase 3CardioKine Inc.NCT00876876Written as Lixivaptan
Codes
What other systems call lixivaptan · ClinicalTrials.gg INT004243
- MeSH (NLM) C409452lixivaptanOne source NLM
- UNII (FDA) 8F5X4B082ELIXIVAPTANConfirmed FDA, NLM, Wikidata
- Wikidata Q6659958lixivaptanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C74429LixivaptanOne source FDA
- DrugBank DB06666One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C409452 | lixivaptan | One source NLM |
| UNII (FDA) | 8F5X4B082E | LIXIVAPTAN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6659958 | lixivaptan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C74429 | Lixivaptan | One source FDA |
| DrugBank | DB06666 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.